Literature DB >> 7491951

Insulin-like growth factor I accelerates protein synthesis in skeletal muscle during sepsis.

C V Jurasinski1, T C Vary.   

Abstract

Sepsis causes an inhibition of protein synthesis in gastrocnemius that is resistant to the anabolic effects of insulin. The purpose of the present studies was to investigate the effect of recombinant human insulin-like growth factor I (IGF-I) on protein synthesis during a 30-min perfusion of the isolated rat hindlimb from septic rats. Inclusion of IGF-I (1 or 10 nM) in the perfusate stimulated protein synthesis in gastrocnemius of septic rats 2.5-fold and restored rates of protein synthesis to those observed in control rats. The stimulation of protein synthesis did not result from an increase in the RNA content but was correlated with a 2.5-fold increase in the translational efficiency. The enhanced translational efficiency was accompanied by a 33 and 55% decrease in the abundance of free 40S and 60S ribosomal subunits, respectively, indicating that IGF-I accelerated peptide-chain initiation relative to elongation/termination. These studies provide evidence that IGF-I can accelerate protein synthesis in gastrocnemius during chronic sepsis by reversing the sepsis-induced inhibition of peptide-chain initiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7491951     DOI: 10.1152/ajpendo.1995.269.5.E977

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  Reduced 40S initiation complex formation in skeletal muscle during sepsis.

Authors:  T C Vary; C Jurasinski; S R Kimball
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

2.  Age and estrogen-based hormone therapy affect systemic and local IL-6 and IGF-1 pathways in women.

Authors:  Maarit Ahtiainen; Eija Pöllänen; Paula H A Ronkainen; Markku Alen; Jukka Puolakka; Jaakko Kaprio; Sarianna Sipilä; Vuokko Kovanen
Journal:  Age (Dordr)       Date:  2011-08-16

3.  Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome.

Authors:  Lori D Wilson; Sadeeka Al-Majid; Cyril S Rakovski; Christina D Schwindt
Journal:  J Inflamm (Lond)       Date:  2012-06-21       Impact factor: 4.981

Review 4.  Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide.

Authors:  Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2020-10-01       Impact factor: 4.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.